Squarepoint
HCAT icon

Squarepoint’s Health Catalyst HCAT Stock Holding History

Squarepoint’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$796K Buy
400,210
+369,772
+1,215% +$534K ﹤0.01% 3077
2026
Q1 		$38.7K Sell
30,438
-158,240
-84% -$298K ﹤0.01% 4155
2025
Q4 		$451K Buy
188,678
+172,379
+1,058% +$471K ﹤0.01% 3292
2025
Q3 		$46.5K Sell
16,299
-28,028
-63% -$95.9K ﹤0.01% 4235
2025
Q2 		$167K Buy
44,327
+7,784
+21% +$30.6K ﹤0.01% 4032
2025
Q1 		$166K Buy
+36,543
New +$193K ﹤0.01% 4084
2024
Q4 		– Sell
-23,708
Closed -$193K – 5201
2024
Q3 		$193K Sell
23,708
-71,755
-75% -$519K ﹤0.01% 3696
2024
Q2 		$610K Sell
95,463
-96,341
-50% -$618K ﹤0.01% 2926
2024
Q1 		$1.44M Buy
191,804
+154,069
+408% +$1.41M ﹤0.01% 2323
2023
Q4 		$349K Buy
+37,735
New +$308K ﹤0.01% 3256
2023
Q3 		– Sell
-10,016
Closed -$125K – 3975
2023
Q2 		$125K Buy
+10,016
New +$119K ﹤0.01% 3319
2023
Q1 		– Sell
-176,530
Closed -$1.88M – 3436
2022
Q4 		$1.88M Buy
176,530
+159,485
+936% +$1.54M 0.01% 1404
2022
Q3 		$165K Sell
17,045
-199,917
-92% -$2.65M ﹤0.01% 2726
2022
Q2 		$3.14M Buy
216,962
+162,297
+297% +$2.77M 0.02% 924
2022
Q1 		$1.43M Buy
54,665
+35,680
+188% +$1.01M 0.01% 1372
2021
Q4 		$752K Buy
18,985
+4,389
+30% +$200K ﹤0.01% 1878
2021
Q3 		$730K Buy
14,596
+2,870
+24% +$157K ﹤0.01% 1750
2021
Q2 		$651K Sell
11,726
-30,155
-72% -$1.61M ﹤0.01% 1951
2021
Q1 		$1.96M Buy
41,881
+3,830
+10% +$186K 0.01% 1082
2020
Q4 		$1.66M Sell
38,051
-8,610
-18% -$318K 0.01% 1036
2020
Q3 		$1.71M Buy
46,661
+7,111
+18% +$241K 0.02% 710
2020
Q2 		$1.15M Buy
+39,550
New +$1.09M 0.02% 858

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Squarepoint's HCAT Position: Q2 2026 in Review

Squarepoint increased its Health Catalyst (HCAT) stake by 1,215% in Q2 2026, buying an estimated $534K and bringing the position to 400,210 shares worth $796K. The position accounts for ﹤0.01% of the portfolio, ranked #3077.

Squarepoint first reported a position in HCAT in Q2 2020 and has held it in 22 quarters since. The position peaked at $3.14M in Q2 2022. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Squarepoint held 400,210 shares of Health Catalyst worth $796K as of Q2 2026.
  • Squarepoint bought 369,772 Health Catalyst shares in Q2 2026, an estimated $534K.
  • Health Catalyst made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3077 holding.
  • Squarepoint first reported a position in Health Catalyst in Q2 2020 and has held it in 22 quarters since.
  • Squarepoint's Health Catalyst position peaked at $3.14M in Q2 2022.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.